On March 23, the Biomedical Materials Frontier and Transformation Summit Roundtable was held at BEST (Changshu) Biomaterials Co., Ltd. The Jiangsu Provincial Proof of Concept Center (Soochow University) 'Biomedical Materials and Intelligent Equipment' branch center and BEST (Changshu) production base were simultaneously launched on site, and a signing and unveiling ceremony was held.
Academicians of the Chinese Academy of Sciences Liu Zhongfan, Ge Junbo, Liu Changsheng, Zhao Dongyuan, Chen Xuesi, Chi Lifeng, Zhang Wei, deputy secretary of the Changshu Municipal Party Committee and mayor, Zhang Zhengbiao, member of the Standing Committee of the Party Committee and Vice President of Suzhou University, and Chen Hong, founder of Jiangsu Baisaifei Biotechnology Co., Ltd. and professor of Suzhou University, attended the event.
Liu Zhongfan said in his speech that my country's basic scientific research has achieved rapid development in the past 30 years. In the face of growing pressure and challenges, the majority of scientific and technological workers must not only have the courage to climb to scientific heights, but also be down-to-earth and transform scientific research results into a powerful driving force for economic and social development. He hoped that this event could further stimulate the innovation enthusiasm and entrepreneurial vitality of the majority of scientific and technological workers, promote deeper and broader exchanges and cooperation between 'government, industry, academia and research' parties, point out the direction for the sustainable development of high-tech enterprises, and provide strong support for the upgrading and transformation of local industries. He fully affirmed and appreciated the phased results achieved by Professor Chen Hong and the Bai Saifei team's commitment to the transformation of scientific and technological achievements.
For a long time, my country's core materials for high-end medical devices have been highly dependent on imports, especially the independent controllability of medical coatings, the key materials for implantable interventional devices, is directly related to industrial safety and patients' lives and health. In this regard, Besaifei has broken through overseas technical barriers by building the first domestic technical service platform covering the entire medical coating industry chain, and has assisted customers in obtaining hundreds of medical device registration certificates certified by NMPA (National Medical Products Administration), FDA (U.S. Food and Drug Administration), CE (European Conformity Certification) and other international authoritative certifications, and its products are exported to global markets. In addition, Besaifei took the lead in formulating the first domestic industry standard for the coating firmness of vascular interventional devices, and released a number of anticoagulant and antibacterial coating-related group standards that filled the domestic gap, becoming an industry benchmark.
As a wholly-owned subsidiary of Bysafe, the production base of Best (Changshu) is one of the very few large-scale pilot and production bases for medical coatings in China that meets the dual standards of hazardous chemicals management and medical product production. The official opening of the base has laid a solid foundation for the continuous transformation of innovative results, large-scale mass production technology iteration and market application expansion of Bysafe.
The 'Biomedical Materials and Intelligent Equipment' sub-center of the Jiangsu Provincial Proof of Concept Center (Soochow University) is jointly built by Soochow University and BEST. With the support of the Changshu Municipal Government and the New Materials Industrial Park, it integrates the scientific research resources of universities and the industrialization advantages of enterprises, focuses on technology evaluation, experimental verification and resource integration, opens up the key links for the transformation of scientific and technological achievements, and helps the region build a national-level biomedical new materials industry highland.
A cutting-edge and transformation roundtable was held at the same time as the conference. A number of academicians and experts from universities, medical institutions, and regulatory authorities discussed the core difficulties in the research and development, industrialization, and clinical application of biomedical materials, and provided suggestions and suggestions for promoting high-quality development of the industry.
Gu Xiangmin, deputy mayor of Changshu City, attended the event and delivered a speech, emphasizing that Changshu will continue to optimize the innovation ecosystem and support the biomedical materials industry to become bigger and stronger.
# About Baisaifei
Jiangsu Baisaifei Biotechnology Co., Ltd. is a national 'specialized and innovative' small giant enterprise in the field of biomaterial surface modification technology. Since its establishment in 2017, it has gone through multiple rounds of financing and expansion and now has nearly 25,000 square meters of R&D and production space. It has taken the lead in creating a technical service platform covering the entire industrial chain of functional coatings, including independently developed multiple series of medical coating products (seven categories including hydrophilic lubrication, anticoagulation, antibacterial, anti-crystallization, and drug release), automated coating equipment/ Production lines, coating AI quality inspection and analytical instruments, it is the company with the most patents related to medical coatings in China. It has led the establishment of the first domestic industry standards related to the fastness of interventional medical device coatings, and has released a number of anti-coagulant, antibacterial and other medical coating-related group standards to fill the domestic gap. It has built one of the very few large-scale production bases for medical coatings in China that meets the dual standards of hazardous chemicals and medical supplies, and has served global medical device manufacturers to obtain hundreds of NMPA, FDA, and CE medical device registration certificates.
